NORTH
CHICAGO, Ill., March 7,
2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will
participate in the Barclays 26th Annual Global Healthcare
Conference on Thursday, March 14,
2024. Robert A. Michael,
president and chief operating officer, Scott T. Reents, executive vice president, chief
financial officer, Jeffrey R.
Stewart, executive vice president, chief commercial officer
and Roopal Thakkar, M.D., senior
vice president, chief medical officer, global therapeutics, will
present at 8:00 a.m. Central
time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas –
immunology, oncology, neuroscience, and eye care – and products and
services in our Allergan Aesthetics portfolio. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
LinkedIn, Facebook, Instagram, X (formerly Twitter), and
YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-barclays-26th-annual-global-healthcare-conference-302082013.html
SOURCE AbbVie